TCRX:NASDAQ
Tscan Therapeutics Inc
$0.34
0.00%
(0.00) 1D
$0.35
arrow_upward
+2.00% (+0.0068)bedtimeAfter hours
Closed: Sep 28, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TCRX...
Open
$0.34
High
$0.35
Low
$0.33
Mkt. cap
23.04M
Avg. vol.
991.64K
Volume
0.00
52-wk high
$2.57
52-wk low
$0.29
EPS
-$0.91
Beta
1.07
Shares outstanding
63.50M
No. of employees
138
Open
$0.34
High
$0.35
Low
$0.33
Mkt. cap
23.04M
Avg. vol.
991.64K
Volume
0.00
52-wk high
$2.57
52-wk low
$0.29
EPS
-$0.91
Beta
1.07
Shares outstanding
63.50M
No. of employees
138
News stories
From web sources and news partners
https://www.dars.gov.et/
·
1 month ago
TCRX Q1 2026 Earnings: Wider-than-Expected Loss Underscores Clinical-Stage Cash Burn - Estimate Uncertainty
www.dars.gov.et
·
2 months ago
TScan Therapeutics (TCRX) Bounces Off Support, Tests Key Resistance at $0.96 - Golden Cross
https://www.dars.gov.et/
·
2 months ago
TScan Therapeutics Q1 2026 Earnings: Wider-than-Expected Loss Amid Pre-Revenue Phase - Management Tone Analysis
About Tscan Therapeutics Inc
CEO-
Employees138
Founded2018
HeadquartersWaltham, Massachusetts, United States
SectorBiotechnology
Websitetscan.com